ENO1 and bladder transitional cell carcinoma: The transwell assays showed that exogenous pyruvate supplementation rescued the inhibitory effect of melatonin treatment or silencing of ENO1 on the metastatic ability of BLCA cells (Fig. 3I, K and Supplementary Fig. S7E, F).